Why the study?
Does the presence of mitral valve prolapse affect the clinical presentation and outcomes of infective endocarditis compared to other types of mitral regurgitation?
Does the presence of mitral valve prolapse affect the clinical presentation and outcomes of infective endocarditis compared to other types of mitral regurgitation?
Answers are grounded in this paper and cite their sources.
Infective endocarditis in patients with mitral valve prolapse has a similar clinical course and prognosis to IE in patients with other types of mitral regurgitation, despite a shorter duration of symptoms prior to diagnosis.
In a review of 350 consecutive patients with infective endocarditis (IE) 14 patients were found to have mitral valve prolapse (MVP) and mitral IE between 1970 and 1982 in our institution. We first describe the clinical features, laboratory findings and follow up of this group; then we compare it with the data obtained in patients with IE with other types of mitral regurgitation (MR). All patients with MVP had a murmur or a click with a murmur before the acute episode of IE, the most frequent consecutive organism was Streptococcus (nine cases) and the response to antimicrobial therapy was good; only one patient died and three others needed a mitral valve replacement from one month to 12 years later. The comparison with other types of mitral regurgitation with IE was done by sex, age, duration of symptoms before IE diagnosis, frequency of atrial fibrillation, number of congestive heart failures, heart volume on chest X-ray, number of echographic vegetations and echographic left ventricle size, and number of mitral valve replacements and deaths. None of these items differed significantly, but the duration of symptoms before diagnosis was shorter in the group of patients with MVP.
No takes yet. Share an insight, caveat, or question.
Roucaut et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: